Is Intraperitoneal Drainage Necessary Following Distal Pancreatectomy?

Status Recruiting

Clinical Trial Summary

The goal of this clinical trial is to analyze if intraperitoneal drainage is necessary following distal pancreatectomy. This study aims to determine whether the omission of routine intraperitoneal drainage in the setting of reinforced staple technology is non-inferior to routine intraperitoneal drainage with respect to a composite post-operative complications of Grade B or C Postoperative pancreatic fistula (POPF), readmission, or organ space surgical site infection following a distal pancreatectomy.

Clinical Trial Description

Pancreatic resections are commonly performed across the United States, yet still represent one of the most morbid abdominal operations in the country, with postoperative mortality as high as 7.7%. Distal pancreatectomy (DP) represents one of the most common approaches to pancreatic resection and is typically used for tumors of the pancreatic body or tail. This operation is known to have a high historic morbidity, with reports of overall morbidity between 12-52%. Common complications include intraabdominal abscess and surgical site infection. Postoperative pancreatic fistula (POPF) represents the most common complication following partial pancreatic resection, with rates reported with rates as high as 30% in multiple large retrospective studies. Multiple strategies to prevent postoperative pancreatic leak following distal pancreatectomy have been studied. One of the outstanding questions that remains is regarding the need for routine intraperitoneal drainage following DP, particularly since the advent of reinforced staple technology. This study aims to determine if intraperitoneal drainage is necessary following DP. This study will compare groups using a composite endpoint of complications. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05720338
Study type	Interventional
Source	Case Comprehensive Cancer Center
Contact	Robert Simon, MD
Phone	1-866-223-8100
Email	TaussigResearch@ccf.org
Status	Recruiting
Phase	Phase 3
Start date	April 13, 2023
Completion date	July 31, 2027

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05351983` - Patient-derived Organoids Drug Screen in Pancreatic Cancer	N/A
Recruiting	`NCT05155878` - Prognostic Factors in Periampullary Tumors and Cysts
Completed	`NCT03834701` - Endoscopic Ultrasound-guided RadioFrequency Ablation for the Treatment Pancreatic NeuroEndocrine Neoplasms	N/A
Recruiting	`NCT04164602` - The Occurence of Pancreatic Cancer Studied in Association With Newly Diagnosed Diabetes in the Elderly
Active, not recruiting	`NCT05095831` - EUS Shear Wave for Solid Pancreatic Lesions.
Recruiting	`NCT04783844` - Usefulness of 3D Digital Reconstruction in the Imaging Diagnosis of Pancreatic Tumors
Recruiting	`NCT03570502` - Incidence of POPF in the Resection of the Left Pancreas With RFAT
Recruiting	`NCT04783831` - Biodegradable Pancreatic Stents for the Prevention of Postoperative Pancreatic Fistula After Cephalic Pancreaticoduodenectomy
Not yet recruiting	`NCT06381882` - The Role of the Human Microbiome in Patients After Pancreatic Resection.
Not yet recruiting	`NCT04336839` - Portal Vein Resection in Pancreatic Neuroendocrine Tumours
Recruiting	`NCT05714111` - Radiology Registry on Pancreatic Malignancies
Recruiting	`NCT05252390` - NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors	Phase 1/Phase 2
Recruiting	`NCT06344507` - Iconographic Registry of Pancreatobiliary Endoscopy Procedures
Recruiting	`NCT04104230` - Quebec Pancreas Cancer Study
Recruiting	`NCT05371223` - Combined Nabpaclitaxel Pressurized IntraPeritoneal Aerosol Chemotherapy With Systemic Nabpaclitaxel-Gemcitabine Chemotherapy for Pancreatic Cancer Peritoneal Metastases	Phase 2
Recruiting	`NCT04687410` - Novel Crown-cut Biopsy Needle (FNB) vs Standard Aspiration Needle (FNA) for EUS-guided Diagnosis of SPLs	N/A
Completed	`NCT04724551` - The Neutrophil-to-Lymphocyte Ratio to Exclude Pancreatic Fistula
Withdrawn	`NCT03649035` - Eus-guided Cryothermal Ablation in Stage III Pancreatic Adenocarcinoma	Phase 3
Recruiting	`NCT04841616` - Multicentered Prospective Randomized Controlled Trial For Solid Pancreatic Lesions	N/A
Completed	`NCT05711433` - Risk Factors for Postoperative Pancreatic Fistula Following Non-traumatic Pancreatic Surgery. Retrospective Observational Study.